Article Information
History
- October 6, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Morgane Mermet1,
- Jessica Denom2,
- Aleksandra Mieczkowska1,
- Emma Biggs3,
- Fiona M. Gribble3,
- Frank Reimann3,
- Christophe Magnan2,
- Celine Cruciani-Guglielmacci2 and
- Guillaume Mabilleau1,4,*
- 1Univ Angers, Nantes Université, ONIRIS, Inserm, RMeS, UMR 1229, SFR ICAT, F-49000, Angers, France
- 2Université Paris Cité, CNRS, BFA, UMR 8251, F-75205, Paris, France
- 3Institute of Metabolic Science & MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, UK
- 4CHU Angers, Departement de Pathologie Cellulaire et Tissulaire, UF de Pathologie osseuse, 49933 Angers, France
- ↵*Correspondence to: Dr Guillaume Mabilleau, Inserm UMR_S 1229 RMeS – REGOS Team, Institut de Biologie en Santé, Université d’Angers, 4 rue Larrey, F-49933 Angers, France. E-mail: guillaume.mabilleau{at}univ-angers.fr
Posted October 06, 2024.
The GLP-1 analogue, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice
